SCAF11: A Protein Involved in Disease Development and Drug Targeting

Target Name: SCAF11

NCBI ID: G9169

SCAF11

SCAF11: A Protein Involved in Disease Development and Drug Targeting

SCAF11 (SRSF2-interacting protein) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and gastrointestinal tract. It is a member of the SRSF2 family of proteins, which are known for their role in cell-cell adhesion and signaling. SCAF11 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, SCAF11 has become a focus of interest for researchers and pharmaceutical companies looking for potential drug targets or biomarkers.

SCAF11 is a 21-kDa protein that is expressed in a variety of tissues, including the brain, heart, liver, and gastrointestinal tract. It is a member of the SRSF2 family of proteins, which are characterized by the presence of a unique C-terminal region that contains a conserved domain called SRSF2. This domain is known to be involved in protein-protein interactions and is thought to play a role in the regulation of cell-cell adhesion.

SCAF11 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of SCAF11 are associated with poor prognosis in patients with colorectal cancer, and that inhibition of SCAF11 has been shown to be effective in treating this type of cancer.

In addition to its potential clinical applications, SCAF11 is also of interest to researchers as a potential drug target. The conserved domain in the SRSF2 family allows for the development of small molecules that can interact with this protein and potentially disrupt its function. This has led to a number of studies aimed at identifying and characterizing SCAF11-interacting molecules, with the goal of developing drugs that can target this protein and improve treatment outcomes for various diseases.

One of the challenges in studying SCAF11 is its complex structure and the limited information that is currently available about its functions. Despite its importance in the development and progression of disease, SCAF11 is still relatively well understood. However, research into its role in cell-cell adhesion and its potential as a drug target is ongoing, and it is likely that this protein will continue to be a focus of interest in the years to come.

In conclusion, SCAF11 is a protein that is known to play a role in the development and progression of various diseases. Its unique structure and its potential as a drug target make it an attractive target for research into the treatment of these diseases. Further studies are needed to fully understand its role in cell-cell adhesion and its potential as a therapeutic agent.

Protein Name: SR-related CTD Associated Factor 11

Functions: Plays a role in pre-mRNA alternative splicing by regulating spliceosome assembly

The "SCAF11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCAF11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets